var singsData = [{"date":new Date(2012,1,16),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2012,1,16),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2012,10,8),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Stifel Nicolaus initiates coverage on XRAY to Hold.","showOnAxis":true},{"date":new Date(2012,10,8),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Stifel Nicolaus initiates coverage on XRAY to Hold.","showOnAxis":false},{"date":new Date(2012,11,26),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.055","showOnAxis":true},{"date":new Date(2012,2,28),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.055","showOnAxis":true},{"date":new Date(2012,4,1),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2012,4,1),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2012,4,2),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Jefferies maintains XRAY to Buy. Target Price is $46; previously $45.","showOnAxis":true},{"date":new Date(2012,4,2),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Jefferies maintains XRAY to Buy. Target Price is $46; previously $45.","showOnAxis":false},{"date":new Date(2012,4,25),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2012,4,25),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Submission of Matters to a Vote of Security Holders\r\n","showOnAxis":true},{"date":new Date(2012,5,27),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.055","showOnAxis":true},{"date":new Date(2012,6,3),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"UBS initiates coverage on XRAY to Neutral. Target Price is $41.","showOnAxis":true},{"date":new Date(2012,6,3),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"UBS initiates coverage on XRAY to Neutral. Target Price is $41.","showOnAxis":false},{"date":new Date(2012,6,31),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, XRAY reports 2012 Q2's earning $0.62 per share and revenue $763MM. This beats analyst's estimated EPS $0.57, beats estimated revenue $747.92MM.","showOnAxis":false},{"date":new Date(2012,6,31),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2012,6,31),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2012,7,1),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Jefferies maintains XRAY to Buy. Target Price is $44; previously $46.","showOnAxis":true},{"date":new Date(2012,7,1),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Jefferies maintains XRAY to Buy. Target Price is $44; previously $46.","showOnAxis":false},{"date":new Date(2012,8,26),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.055","showOnAxis":true},{"date":new Date(2012,9,22),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"UBS downgrades XRAY to Sell from Neutral. Target Price is $35; previously $39.","showOnAxis":true},{"date":new Date(2012,9,22),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"UBS downgrades XRAY to Sell from Neutral. Target Price is $35; previously $39.","showOnAxis":false},{"date":new Date(2012,9,24),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2012,9,24),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2012,9,25),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, XRAY reports 2012 Q3's earning $0.37 per share and revenue $695.73MM..","showOnAxis":false},{"date":new Date(2013,1,20),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, XRAY reports 2012 Q4's earning $0.56 per share and revenue $753.3MM. This meets analyst's estimated EPS $0.56, beats estimated revenue $742.7MM.","showOnAxis":false},{"date":new Date(2013,1,20),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2013,1,20),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2013,1,21),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"UBS maintains XRAY to Sell. Target Price is $38; previously $35.","showOnAxis":true},{"date":new Date(2013,1,21),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Wellington Shields downgrades XRAY to Hold from Gradually Accumulate.","showOnAxis":true},{"date":new Date(2013,1,21),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"UBS maintains XRAY to Sell. Target Price is $38; previously $35.","showOnAxis":false},{"date":new Date(2013,1,21),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Wellington Shields downgrades XRAY to Hold from Gradually Accumulate.","showOnAxis":false},{"date":new Date(2013,11,11),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Credit Suisse upgrades XRAY to Outperform from Neutral.","showOnAxis":false},{"date":new Date(2013,11,11),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Goldman Sachs upgrades XRAY to Buy from Neutral. Target Price is $56; previously $45.","showOnAxis":false},{"date":new Date(2013,11,24),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.063","showOnAxis":true},{"date":new Date(2013,2,26),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.063","showOnAxis":true},{"date":new Date(2013,3,15),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Citigroup upgrades XRAY to Buy from Neutral. Target Price is $49; previously $39.65.","showOnAxis":false},{"date":new Date(2013,3,8),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2013,3,8),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2013,4,20),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Barrington Research downgrades XRAY to Market Perform from Outperform.","showOnAxis":true},{"date":new Date(2013,4,20),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Barrington Research downgrades XRAY to Market Perform from Outperform.","showOnAxis":false},{"date":new Date(2013,4,23),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2013,4,23),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Submission of Matters to a Vote of Security Holders\r\n","showOnAxis":true},{"date":new Date(2013,4,8),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2013,4,8),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2013,4,9),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, XRAY reports 2013 Q1's earning $0.52 per share and revenue $732.1MM. This misses analyst's estimated EPS $0.56, misses estimated revenue $732.87MM.","showOnAxis":false},{"date":new Date(2013,5,26),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.063","showOnAxis":true},{"date":new Date(2013,7,1),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, XRAY reports 2013 Q2's earning $0.66 per share and revenue $761.01MM. This beats analyst's estimated EPS $0.65, misses estimated revenue $782.73MM.","showOnAxis":false},{"date":new Date(2013,7,1),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2013,7,1),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2013,7,27),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2013,7,27),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Issue new debts or other obligations.\r\n","showOnAxis":true},{"date":new Date(2013,7,6),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Northcoast Research downgrades XRAY to Neutral from Buy.","showOnAxis":true},{"date":new Date(2013,7,6),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Northcoast Research downgrades XRAY to Neutral from Buy.","showOnAxis":false},{"date":new Date(2013,8,25),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.063","showOnAxis":true},{"date":new Date(2013,9,29),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, XRAY reports 2013 Q3's earning $0.57 per share and revenue $704MM. This beats analyst's estimated EPS $0.56, misses estimated revenue $716.13MM.","showOnAxis":false},{"date":new Date(2013,9,29),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2013,9,29),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2013,9,4),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Bank of America upgrades XRAY to Buy from Underperform. Target Price is $48; previously $35.","showOnAxis":false},{"date":new Date(2014,1,18),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"After market close, XRAY reports 2013 Q4's earning $0.61 per share and revenue $753.7MM. This meets analyst's estimated EPS $0.61, misses estimated revenue $767.89MM.","showOnAxis":false},{"date":new Date(2014,1,18),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2014,1,18),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2014,11,23),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.066","showOnAxis":true},{"date":new Date(2014,2,26),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.066","showOnAxis":true},{"date":new Date(2014,4,16),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Barrington Research upgrades XRAY to Outperform from Market Perform.","showOnAxis":false},{"date":new Date(2014,4,21),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2014,4,21),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Submission of Matters to a Vote of Security Holders\r\n","showOnAxis":true},{"date":new Date(2014,4,6),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2014,4,6),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2014,5,25),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.066","showOnAxis":true},{"date":new Date(2014,6,31),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2014,6,31),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2014,8,24),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.066","showOnAxis":true},{"date":new Date(2014,8,24),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2014,8,24),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Issue new debts or other obligations.\r\n","showOnAxis":true},{"date":new Date(2014,9,20),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Goldman Sachs downgrades XRAY to Neutral from Buy.","showOnAxis":true},{"date":new Date(2014,9,20),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Goldman Sachs downgrades XRAY to Neutral from Buy.","showOnAxis":false},{"date":new Date(2014,9,29),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2014,9,29),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2014,9,30),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Credit Suisse maintains XRAY to Outperform. Target Price is $55; previously $54.","showOnAxis":true},{"date":new Date(2014,9,30),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Credit Suisse maintains XRAY to Outperform. Target Price is $55; previously $54.","showOnAxis":false},{"date":new Date(2015,0,2),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Baird downgrades XRAY to Neutral from Outperform. Target Price is $55.","showOnAxis":true},{"date":new Date(2015,0,2),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Baird downgrades XRAY to Neutral from Outperform. Target Price is $55.","showOnAxis":false},{"date":new Date(2015,0,22),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Barrington Research assumes XRAY to Market Perform.","showOnAxis":true},{"date":new Date(2015,0,22),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Barrington Research assumes XRAY to Market Perform.","showOnAxis":false},{"date":new Date(2015,1,18),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,1,18),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2015,10,13),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,10,13),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2015,10,20),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,10,20),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2015,11,10),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2015,11,10),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,11,11),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Entry into a Material Definitive Agreement\r\n","showOnAxis":true},{"date":new Date(2015,11,11),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,11,11),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Issue new debts or other obligations.\r\n","showOnAxis":true},{"date":new Date(2015,11,11),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2015,11,22),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.073","showOnAxis":true},{"date":new Date(2015,2,25),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.072","showOnAxis":true},{"date":new Date(2015,4,20),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year\r\n","showOnAxis":true},{"date":new Date(2015,4,20),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2015,4,20),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,4,20),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Submission of Matters to a Vote of Security Holders\r\n","showOnAxis":true},{"date":new Date(2015,4,22),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Costs Associated with Exit or Disposal Activities\r\n","showOnAxis":true},{"date":new Date(2015,4,22),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,4,6),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,4,6),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2015,5,24),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.073","showOnAxis":true},{"date":new Date(2015,6,30),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,6,30),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2015,6,31),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Credit Suisse maintains XRAY to Outperform. Target Price is $63; previously $61.","showOnAxis":true},{"date":new Date(2015,6,31),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Credit Suisse maintains XRAY to Outperform. Target Price is $63; previously $61.","showOnAxis":false},{"date":new Date(2015,8,14),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Morgan Stanley upgrades XRAY to Overweight.","showOnAxis":false},{"date":new Date(2015,8,15),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Entry into a Material Definitive Agreement\r\n","showOnAxis":true},{"date":new Date(2015,8,15),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,8,15),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2015,8,16),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Baird upgrades XRAY to Outperform. Target Price is $61; previously $58.","showOnAxis":false},{"date":new Date(2015,8,16),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Barrington Research upgrades XRAY to Outperform from Market Perform. Target Price is $60.","showOnAxis":false},{"date":new Date(2015,8,16),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Bank of America maintains XRAY to Buy. Target Price is $65; previously $60.","showOnAxis":true},{"date":new Date(2015,8,16),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Bank of America maintains XRAY to Buy. Target Price is $65; previously $60.","showOnAxis":false},{"date":new Date(2015,8,21),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Northcoast Research upgrades XRAY to Outperform from Market Perform.","showOnAxis":false},{"date":new Date(2015,8,21),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"William Blair upgrades XRAY to Outperform.","showOnAxis":false},{"date":new Date(2015,8,23),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.073","showOnAxis":true},{"date":new Date(2015,9,28),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,9,28),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2015,9,28),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2015,9,29),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,9,29),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2016,0,11),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2016,0,11),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2016,0,11),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Submission of Matters to a Vote of Security Holders\r\n","showOnAxis":true},{"date":new Date(2016,1,12),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2016,1,12),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2016,1,25),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"UBS upgrades XRAY to Neutral from Sell. Target Price is $60.","showOnAxis":false},{"date":new Date(2016,1,29),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year\r\n","showOnAxis":true},{"date":new Date(2016,1,29),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2016,1,29),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Completion of Acquisition or Disposition of Assets\r\n","showOnAxis":true},{"date":new Date(2016,1,29),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2016,1,29),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2016,10,1),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Morgan Stanley upgrades XRAY to Overweight from Equal-Weight.","showOnAxis":false},{"date":new Date(2016,10,4),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, XRAY reports 2016 Q3's earning $0.66 per share and revenue $954.2MM. This beats analyst's estimated EPS $0.63, misses estimated revenue $968.1MM.","showOnAxis":false},{"date":new Date(2016,10,4),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2016,10,4),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2016,11,28),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.078","showOnAxis":true},{"date":new Date(2016,11,5),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Barrington Research upgrades XRAY to Outperform from Market Perform.","showOnAxis":false},{"date":new Date(2016,2,14),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"William Blair downgrades XRAY to Market Perform from Outperform.","showOnAxis":true},{"date":new Date(2016,2,14),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"William Blair downgrades XRAY to Market Perform from Outperform.","showOnAxis":false},{"date":new Date(2016,2,15),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Credit Suisse initiates coverage on XRAY to Outperform. Target Price is $70.","showOnAxis":true},{"date":new Date(2016,2,15),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Credit Suisse initiates coverage on XRAY to Outperform. Target Price is $70.","showOnAxis":false},{"date":new Date(2016,2,22),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.078","showOnAxis":true},{"date":new Date(2016,2,24),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Morgan Stanley downgrades XRAY to Equal-Weight from Overweight. Target Price is $65.","showOnAxis":true},{"date":new Date(2016,2,24),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Morgan Stanley downgrades XRAY to Equal-Weight from Overweight. Target Price is $65.","showOnAxis":false},{"date":new Date(2016,2,3),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Jefferies upgrades XRAY to Buy from Neutral. Target Price is $70; previously $60.","showOnAxis":false},{"date":new Date(2016,4,25),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2016,4,25),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Submission of Matters to a Vote of Security Holders\r\n","showOnAxis":true},{"date":new Date(2016,4,6),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, XRAY reports 2016 Q1's earning $0.69 per share and revenue $772.6MM. This beats analyst's estimated EPS $0.63, beats estimated revenue $734.75MM.","showOnAxis":false},{"date":new Date(2016,4,6),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2016,4,6),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2016,5,13),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"PiperJaffray initiates coverage on XRAY to Overweight.","showOnAxis":true},{"date":new Date(2016,5,13),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"PiperJaffray initiates coverage on XRAY to Overweight.","showOnAxis":false},{"date":new Date(2016,5,22),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.078","showOnAxis":true},{"date":new Date(2016,5,27),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2016,5,27),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2016,7,5),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, XRAY reports 2016 Q2's earning $0.76 per share and revenue $1022MM. This beats analyst's estimated EPS $0.7, misses estimated revenue $1030MM.","showOnAxis":false},{"date":new Date(2016,7,5),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2016,7,5),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2016,7,8),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Barrington Research downgrades XRAY to Market Perform from Outperform.","showOnAxis":true},{"date":new Date(2016,7,8),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Barrington Research downgrades XRAY to Market Perform from Outperform.","showOnAxis":false},{"date":new Date(2016,8,22),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"JP Morgan initiates coverage on XRAY to Neutral.","showOnAxis":true},{"date":new Date(2016,8,22),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"JP Morgan initiates coverage on XRAY to Neutral.","showOnAxis":false},{"date":new Date(2016,8,28),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.078","showOnAxis":true},{"date":new Date(2016,9,27),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Entry into a Material Definitive Agreement\r\n","showOnAxis":true},{"date":new Date(2016,9,27),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2016,9,27),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Issue new debts or other obligations.\r\n","showOnAxis":true}];